SYMABIO

What SYMABIO does

SYMABIO is registered as an entity headquartered in Antananarivo, Madagascar, with a stated founding year of 1991 and a workforce of 9 employees. The company's only identified digital touchpoint is its website at symabio.mg. The available source data does not disclose the company's sector, product offering, customer base, revenue model, ownership structure, or management team.

The corpus retrieved from the corporate website returned only a generic loading and human-verification page ("One moment, please... Loader... Please wait while your request is being verified"), with no substantive content describing the business. All structured fields covering products and services, technology stack, partnerships, certifications, customers, management, funding, and regulatory history are empty in the source data. The .mg country-code top-level domain and Antananarivo headquarters are the only geographic confirmations available.

Given the absence of descriptive content, no factual statement can be made about what SYMABIO produces, sells, or whom it serves. The 30+ year nominal operating history combined with a 9-person headcount suggests a very small, long-tenured micro-enterprise, but the functional description of the business cannot be grounded in the supplied evidence and is therefore not asserted.

Name

SYMABIO

Website

https://symabio.mg

Company type

Private

Headcount range

1–10 employees

Short description

SYMABIO is a Madagascar-based micro-enterprise headquartered in Antananarivo, registered since 1991 with 9 employees; its specific products, customers, and business activity are not disclosed in the available source data.

Ownership category

akta.pro rank

Product category

Undetermined — insufficient public data from SYMABIO's website to classify the company's primary product or industry category.

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)

akta.pro secondary industry

Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Biological products
• Agricultural commodities
• Natural extracts
• Essential oils
• Organic ingredients

GTM type

B2B

Offering type

Services

Core offering

No substantive description of SYMABIO's core offering could be extracted. The company's website (https://www.symabio.mg/) returned only a "One moment, please... Please wait while your request is being verified..." loader page and did not expose any product, service, or capability content.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• CosmosID: Microbiome analytics and bioinformatics platform offering sequencing-based identification and characterization of microbial communities. Comparable to SYMABIO as a candidate microbiome analytics, sequencing, and bioinformatics services provider.
• Clinical Microbiomics: Specialist provider of microbiome and metagenomics sequencing and bioinformatics services for research and clinical clients. Comparable to SYMABIO as a candidate microbiome analytics and metagenomics services provider, but operating at significantly greater scale.

Broad incumbents

• INRAE (Institut national de recherche pour l'agriculture, l'alimentation et l'environnement): Major French public research institute with extensive microbiome, metagenomics, and soil/plant/animal microbiota programs. Comparable to SYMABIO because both operate in microbiome science and biological research services, though INRAE is a much larger incumbent.
• Zymo Research: Provider of microbiome sample collection, nucleic acid extraction, and microbiome analysis tools and services. Comparable to SYMABIO in serving microbiome and metagenomics workflows, but as a global products and services incumbent.

Emerging players

• Second Genome: Microbiome drug discovery and analytics platform combining microbiome science with bioinformatics. Comparable to SYMABIO in the microbiome therapeutics and analytics domain, though focused on human health drug programs.
• Viome Life Sciences: Microbiome diagnostics and biomarker platform serving consumer and clinical markets with gut/oral microbiome testing. Comparable to SYMABIO as a microbiome diagnostics and biomarker platform, but operating as a consumer-facing digital health company.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat1 record

Customer concentration

• LinkedInlinkedin.com/company/symabio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SYMABIO